Carbamazepine and its metabolites in wastewater: Analytical pitfalls and occurrence in Germany and Portugal

Water Research

Volumn 57, Issue , 2014, Pages 104-114

  Bahlmann, Arnold ^a   Brack, Werner ^a   Schneider, Rudolf J ^b   Krauss, Martin ^a  

^a HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^b BAM FEDERAL INSTITUTE FOR MATERIALS RESEARCH AND TESTING   (Germany)

Author keywords

Carbamazepine; Hydroxycarbamazepine; LC MS MS; Metabolite; Pharmaceutical; Wastewater

Indexed keywords

AMIDES; BIOMOLECULES; EFFLUENTS; ISOMERS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; WASTEWATER TREATMENT;

CARBAMAZEPINE; EPOXY; HYDROXYCARBAMAZEPINE; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; LIQUID-CHROMATOGRAPHY-MS/MS; NO REMOVAL; OH -; OXCARBAZEPINE; PORTUGAL;

METABOLITES;

CARBAMAZEPINE; DRUG METABOLITE; ANTICONVULSIVE AGENT; OXCARBAZEPINE; WASTE WATER; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); DRUG; HYDROXYL RADICAL; METABOLITE; POLLUTANT REMOVAL; WASTEWATER;

ARTICLE; DEUTERIUM HYDROGEN EXCHANGE; DRUG ANALYSIS; EFFLUENT; GERMANY; ISOMER; LIQUID CHROMATOGRAPHY; PORTUGAL; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; WASTE WATER; WASTE WATER MANAGEMENT; ANALOGS AND DERIVATIVES; ANALYSIS; ENVIRONMENTAL MONITORING; MASS SPECTROMETRY; SEWAGE; WATER POLLUTANT;

GERMANY; PORTUGAL;

ANTICONVULSANTS; CARBAMAZEPINE; CHROMATOGRAPHY, LIQUID; DEUTERIUM EXCHANGE MEASUREMENT; ENVIRONMENTAL MONITORING; GERMANY; MASS SPECTROMETRY; PORTUGAL; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84897486637     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2014.03.022     Document Type: Article

References (40)

1. Axelrod J., Inscoe J.K., Tomkins G.M. Enzymatic synthesis of N-glucosyluronic acid conjugates. J. Biol. Chem. 1958, 232(2):835-842.
2. Bahlmann A., Weller M.G., Panne U., Schneider R.J. Monitoring carbamazepine in surface and wastewaters by an immunoassay based on a monoclonal antibody. Anal. Bioanal. Chem. 2009, 395(6):1809-1820.
3. Bahlmann A., Carvalho J.J., Weller M.G., Panne U., Schneider R.J. Immunoassays as high-throughput tools: monitoring spatial and temporal variations of carbamazepine, caffeine and cetirizine in surface and wastewaters. Chemosphere 2012, 89(11):1278-1286.
4. Bauer J.E., Gerber N., Lynn R.K., Smith R.G., Thompson R.M. A new N-glucuronide metabolite of carbamazepine. Cell. Mol. Life Sci. 1976, 32(8):1032-1033.
5. Bernus I., Dickinson R.G., Hooper W.D., Eadie M.J. The mechanism of the carbamazepine-valproate interaction in humans. Br. J. Clin. Pharmacol. 1997, 44(1):21-27.
6. Calisto V., Bahlmann A., Schneider R.J., Esteves V.I. Application of an ELISA to the quantification of carbamazepine in ground, surface and wastewaters and validation with LC-MS/MS. Chemosphere 2011, 84:1708-1715.
7. Celiz M.D., Perez S., Barcelo D., Aga D.S. Trace analysis of polar pharmaceuticals in wastewater by LC-MS-MS: comparison of membrane bioreactor and activated sludge systems. J. Chromatogr. Sci. 2009, 47(1):19-25.
8. Clara M., Strenn B., Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 2004, 38(4):947-954.
9. Cuyckens F., Wassvik C., Mortishire-Smith R.J., Tresadern G., Campuzano I., Claereboudt J. Product ion mobility as a promising tool for assignment of positional isomers of drug metabolites. Rapid Commun. Mass Spectrom. 2011, 25(23):3497-3503.
10. Faigle J.W., Brechbühler S., Feldmann K.F., Richter W.J. The biotransformation of carbamazepine. Epileptic Seizures - Behaviour - Pain 1976, 127-140. University Park Press, London. W. Birkmayer (Ed.).
11. Faigle J.W., Feldmann K.F. Pharmacokinetic data of carbamazepine and its major metabolites in man. Clinical Pharmacology of Antiepileptic Drugs 1975, 159-165. Springer, Berlin. H. Schneider (Ed.).
12. Furst S.M., Sukhai P., McClelland R.A., Uetrecht J.P. Covalent binding of carbamazepine oxidative metabolites to neutrophils. Drug Metab. Dispos. 1995, 23(5):590-594.
13. Furst S.M., Uetrecht J.P. Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils. Biochem. Pharmacol. 1993, 45(6):1267-1275.
14. Gomes R.L., Scrimshaw M.D., Lester J.N. Fate of conjugated natural and synthetic steroid estrogens in crude sewage and activated sludge batch studies. Environ. Sci. Technol. 2009, 43(10):3612-3618.
15. Hummel D., Löffler D., Fink G., Ternes T.A. Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environ. Sci. Technol. 2006, 40(23):7321-7328.
16. Huntscha S., Singer H.P., McArdell C.S., Frank C.E., Hollender J. Multiresidue analysis of 88 polar organic micropollutants in ground, surface and wastewater using online mixed-bed multilayer solid-phase extraction coupled to high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2012, 1268(0):74-83.
17. Ju C., Uetrecht J.P. Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. J. Pharmacol. Exp. Ther. 1999, 288(1):51-56.
18. Kaiser E., Prasse C., Bröder K., Ternes T. Transformation of Three Human Metabolites of Carbamazepine During Sand Filtration 2013, SETAC Europe 23rd Annual Meeting, Glasgow.
19. Keen O.S., Baik S., Linden K.G., Aga D.S., Love N.G. Enhanced biodegradation of carbamazepine after UV/H2O2 advanced oxidation. Environ. Sci. Technol. 2012, 46(11):6222-6227.
20. Kerr B.M., Thummel K.E., Wurden C.J., Klein S.M., Kroetz D.L., Gonzalez F.J., Levy R. Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem. Pharmacol. 1994, 47(11):1969-1979.
21. Kitteringham N.R., Davis C., Howard N., Pirmohamed M., Park B.K. Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10,11-epoxide and naphthalene. J. Pharmacol. Exp. Ther. 1996, 278(3):1018-1027.
22. Kriemler P., Richter W.J. In situ methylation and/or FD-MS: a comparative study of their usefulness in the structure analysis of highly polar metabolites. Recent Developments in Mass Spectrometry in Biochemistry and Medicine 1978, 343-352. Plenum Press, New York. A. Frigerio (Ed.).
23. Leclercq M., Mathieu O., Gomez E., Casellas C., Fenet H., Hillaire-Buys D. Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants. Arch. Environ. Contam. Toxicol. 2009, 56(3):408-415.
24. Maggs J.L., Pirmohamed M., Kitteringham N.R., Park B.K. Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography mass spectrometry. Drug Metab. Dispos. 1997, 25(3):275-280.
25. Miao X.S., Metcalfe C.D. Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry. Anal. Chem. 2003, 75(15):3731-3738.
26. Miao X.S., Yang J.J., Metcalfe C.D. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ. Sci. Technol. 2005, 39(19):7469-7475.
27. Ortiz de García S., Pinto G.P., García-Encina P.A., Mata R.I. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case. J. Environ. Manage. 2013, 129(0):384-397.
28. Pearce R.E., Vakkalagadda G.R., Leeder J.S. Pathways of carbamazepine bioactivation invitro I. Characterization of human cytochromes P450 responsible for the formation of 2-and 3-hydroxylated metabolites. Drug. Metab. Dispos. 2002, 30(11):1170-1179.
29. Richter W.J., Kriemler P., Faigle J.W. Newer aspects of the biotransformation of carbamazepine: structural characterization of highly polar metabolites. Recent Developments in Mass Spectrometry in Biochemistry and Medicine 1978, 1-14. Plenum Press, New York. A. Frigerio (Ed.).
30. 14C-oxcarbazepine in man. Xenobiotica 1986, 16(8):769-778.
31. Schwabe U. Antiepileptika. Arzneiverordnungs-Report 2012 2012, 387-402. Springer, Heidelberg. U. Schwabe, D. Paffrath (Eds.).
32. Smith R.M., Burr C.M. Retention prediction of analytes in reversed-phase high-performance liquid chromatography based on molecular structure: VI. Disubstituted aromatic compounds. J. Chromatogr. A 1991, 550(0):335-356.
33. Ternes T.A. Analytical methods for the determination of pharmaceuticals in aqueous environmental samples. TRAC Trend. Anal. Chem. 2001, 20(8):419-434.
34. Ternes T.A., Kreckel P., Mueller J. Behaviour and occurrence of estrogens in municipal sewage treatment plants- II. Aerobic batch experiments with activated sludge. Sci. Total Environ. 1999, 225(1-2):91-99.
35. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res. 2007, 41(5):1001-1012.
36. Wad N., Guenat C., Krämer G. Carbamazepine: detection of another metabolite in serum, 9-hydroxymethyl-10-carbamoyl acridan. Ther. Drug. Monit. 1997, 19(3):314-317.
37. WHO World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology: ATC/DDD Index 2013 2013, accessed on 30/11/2013. http://www.whocc.no/atcddd/.
38. Zhang Y., Geißen S.-U., Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73(8):1151-1161.
39. Zhao X., Metcalfe C.D. Characterizing and compensating for matrix effects using atmospheric pressure chemical ionization liquid chromatography-tandem mass spectrometry: analysis of neutral pharmaceuticals in municipal wastewater. Anal. Chem. 2008, 80(6):2010-2017.
40. Zuehlke S., Duennbier U., Heberer T. Determination of polar drug residues in sewage and surface water applying liquid chromatography-tandem mass spectrometry. Anal. Chem. 2004, 76(22):6548-6554.